高血压前期的研究进展(2)
[7] Levy D, Carrison RJ, savagy DD,ee al, progno salac implicalions of echocarcliographacally determinyal leftventericular mass in the Framingham Heart Study[J],N Engl J Med,1990.322(22):1561-1566
[8] Drukteinis JS Roman MJ .Fabsitz RR,etal,Gardiac and syatemic henodybamic characterics of hypertension and prehypcrlension inadolaccrls and yong adults:the Strong Hear Study [J], Circulation ,2007.115 (2):221-227
[9] MarKus MR, Stritibe J, Lieh W, etal .lmpliontions of persistent prhypertension for agting-related changes in left vertricular geomety and function:The MONICA∕KORA Augsburg stday[J],Hygertens,2008.26 (10):2040-2049
[10] 王薇，赵东，厚雷等1331人基线血压水平及十年血压变化与颈动脉粥样硬化的研究[J],中华心血管杂志，2006，11(32)：1017-1020
[11] 印小荣，段宝祥，何晓虹，血压正常高值对动脉内膜-中膜厚度(IMT)的影响[J] 南京医科大学学报(自然科学版)，2005,11(25):813-816
[12] Kin BJ ,Lee HJ, Sung KC ,etal ,Comparison of microalbuminuria in Z blood prersure categories of prchyperlensive subjccts[J],Cire,2007,71(8)：1283-1287
[13] Lee JE. Kim YG, Choi YH.etal.Serumacid with microalbuminuria in prehypertension[J]，Hypertension,2006,47(5):588-595
[14]Ninomiya.T,Kubo M,Doi Y, et al,prehypertersion incrascs the riak for renal artenioscIerosis in aulopsies the Hisayama Study[J],JAMSoc Nephml,2007,18(7):1235-2142
[15] Nissen SE ,Tuzcu EM ,Libby P,et al. CAMELOT Investigators.Effect of antihypertensiv agents on cardiovascular events in patients with coronary disease ang normal blood pressure: the CAMELOTstudy:arandomized controlled trial[J],JAMA,2004,292:2217-2225
[16]Mancia G, De Backer G,Dominiczak A, et al. ESH-ESC task force on the Management of Arterial Hypertension. 2007 ESH-ESC practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. [J].J Hypertens,2007,25:1751-1762.
[17] Julius S, Nesbitt SD Egan BM, et al.Trial of Preventing Hypertension(TROPHY) Study Invetigators. Feasibility of treating prehy-pertension with an angiotensin-receptor blocker [J]. The New England Journal of medicine,2006,354:1685-1697., http://www.100md.com(王质义)
[8] Drukteinis JS Roman MJ .Fabsitz RR,etal,Gardiac and syatemic henodybamic characterics of hypertension and prehypcrlension inadolaccrls and yong adults:the Strong Hear Study [J], Circulation ,2007.115 (2):221-227
[9] MarKus MR, Stritibe J, Lieh W, etal .lmpliontions of persistent prhypertension for agting-related changes in left vertricular geomety and function:The MONICA∕KORA Augsburg stday[J],Hygertens,2008.26 (10):2040-2049
[10] 王薇，赵东，厚雷等1331人基线血压水平及十年血压变化与颈动脉粥样硬化的研究[J],中华心血管杂志，2006，11(32)：1017-1020
[11] 印小荣，段宝祥，何晓虹，血压正常高值对动脉内膜-中膜厚度(IMT)的影响[J] 南京医科大学学报(自然科学版)，2005,11(25):813-816
[12] Kin BJ ,Lee HJ, Sung KC ,etal ,Comparison of microalbuminuria in Z blood prersure categories of prchyperlensive subjccts[J],Cire,2007,71(8)：1283-1287
[13] Lee JE. Kim YG, Choi YH.etal.Serumacid with microalbuminuria in prehypertension[J]，Hypertension,2006,47(5):588-595
[14]Ninomiya.T,Kubo M,Doi Y, et al,prehypertersion incrascs the riak for renal artenioscIerosis in aulopsies the Hisayama Study[J],JAMSoc Nephml,2007,18(7):1235-2142
[15] Nissen SE ,Tuzcu EM ,Libby P,et al. CAMELOT Investigators.Effect of antihypertensiv agents on cardiovascular events in patients with coronary disease ang normal blood pressure: the CAMELOTstudy:arandomized controlled trial[J],JAMA,2004,292:2217-2225
[16]Mancia G, De Backer G,Dominiczak A, et al. ESH-ESC task force on the Management of Arterial Hypertension. 2007 ESH-ESC practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. [J].J Hypertens,2007,25:1751-1762.
[17] Julius S, Nesbitt SD Egan BM, et al.Trial of Preventing Hypertension(TROPHY) Study Invetigators. Feasibility of treating prehy-pertension with an angiotensin-receptor blocker [J]. The New England Journal of medicine,2006,354:1685-1697., http://www.100md.com(王质义)